Evidence map›Paper›PMID 31665374›Full record

ArticleJournal of radiation research2019

Japanese Structure Survey of Radiation Oncology in 2011.

Hodaka Numasaki, Teruki Teshima, Tetsuo Nishimura, Keizo Akuta, Yutaka Ando, Hiroshi Ikeda, Norihiko Kamikonya, Masahiko Koizumi, Tomonari Sasaki, Kenji Sekiguchi and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 1 country.

Hodaka NumasakiDepartment of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.
Teruki TeshimaDepartment of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka-shi, Osaka, 541-8567, Japan.
Tetsuo NishimuraDivision of Radiation Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Keizo AkutaDepartment of Radiology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu-shi, Siga, 520-0000, Japan.
Yutaka AndoDepartment of Radiation Oncology, Saitama Medical Center, 4-9-3 Kitaurawa, Urawa-ku, Saitama-shi, Saitama, 330-0074, Japan.
Hiroshi IkedaDepartment of Radiation Oncology, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai-shi, Osaka, 593-8304, Japan.
Norihiko KamikonyaDepartment of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya-shi, Hyogo, 663-8501, Japan.
Masahiko KoizumiDepartment of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.
Tomonari SasakiDivision of Medical Quantum Science, Department of Health Sciences, Kyushu University Faculty of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-8582, Japan.
Kenji SekiguchiSonoda-kai Radiation Oncology Clinic, 3-4-19 Hokima, Adachi-ku, Tokyo, 121-0064, Japan.
Masao TagoDepartment of Radiology, Teikyo University Mizonokuchi Hospital, 5-1-1 Futako, Takatsu, Kawasaki-shi, Kanagawa, 213-8507, Japan.
Atsuro TeraharaDepartment of Radiology, Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan.
Katsumasa NakamuraDepartment of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, 431-3192, Japan.
Masamichi NishioHokkaido Cancer Center, 2-3-54 Kikusui 4jyo, Shiraishi-ku, Sapporo-shi, Hokkaido, 003-0804, Japan.
Masao MurakamiSouthern TOHOKU Proton Therapy Center, 172-7 Yatsuyamada, Koriyama-shi, Fukushima, 963-8563, Japan.
Yoshimasa MoriDepartment of Radiology and Radiation Oncology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute-shi, Aichi, 480-1195, Japan.
Kazuhiko OgawaDepartment of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.
Japanese Society for Radiation Oncology Database Committee
Osaka University · JPAichi Medical University · JPEbara (Japan) · JPHamamatsu University Hospital · JPHyogo Medical University · JPKyushu University · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JPOtsu Red Cross Hospital · JPShizuoka Cancer Center · JPSocial Insurance Saitama Chuo Hospital · JPSouthern Tohoku General Hospital · JPTeikyo University · JPToho University Omori Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the evolving structure of radiation oncology in Japan in terms of equipment, personnel, patient load and geographic distribution to identify and overcome any existing limitations. From March 2012 to August 2015, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2011. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 211 000 and 250 000, respectively. Additionally, the estimated cancer incidence was 851 537 cases with approximately 24.8% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (LINAC; n = 836), telecobalt (n = 3), Gamma Knife (n = 46), 60Co remote afterloading system (RALS; n = 24), and 192Ir RALS (n = 125). The LINAC system used dual-energy functions in 619 units, 3D conformal radiotherapy functions in 719 and intensity-modulated radiotherapy (IMRT) functions in 412. There were 756 JRS or JASTRO-certified radiation oncologists, 1018.5 full-time equivalent (FTE) radiation oncologists, 2026.7 FTE radiotherapy technologists, 149.1 FTE medical physicists, 141.5 FTE radiotherapy quality managers and 716.3 FTE nurses. The frequency of IMRT use significantly increased during this time. To conclude, although there was a shortage of personnel in 2011, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility.

Indexed as

Surveys and QuestionnairesHealth PersonnelHumansJapanNeoplasmsParticle AcceleratorsRadiation Oncologyradiotherapy equipmentradiotherapy institutionradiotherapy personnelstructure survey

Identifiers

PMID31665374
PMCPMC7357227
OpenAlexW2982329004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.